RS

Rakesh Singh

Active Director Director DIN 05278202
DIN 05278202 First appointment Jun 2012 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2012
Shareholding value •••• Premium profile

About Rakesh Singh

Data last updated:

Rakesh Singh is a Director at Br Biochem Life Sciences Private Limited (since 2012). The company operates in Healthcare. Br Biochem Life Sciences Private Limited reported revenue of ₹14.57 Cr (FY 2025).

DIN 05278202
Primary Designation Director
Industry Healthcare
First Appointment 13 Jun 2012
Oldest Company Age 14 yrs
Largest company Br Biochem Life Sciences Private Limited · ₹14.57 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Jun 20122012₹14.57 Cr (FY 2025)Active

Board colleagues of Rakesh Singh

NameDINCompanyDesignation
Babita Negi05278200Br Biochem Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Br Biochem Life Sciences Private Limited
Premium access

Shareholding and investment profile for Rakesh Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Singh

Rakesh Singh currently holds 1 directorship: Br Biochem Life Sciences Private Limited (Director, since 13 Jun 2012, revenue ₹14.57 Cr (FY 2025)).

Rakesh Singh was first appointed on 13 Jun 2012 as Director at Br Biochem Life Sciences Private Limited.

The current boards of Rakesh Singh's companies include Babita Negi (Br Biochem Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available